Evolent Health (EVH) Payables (2015 - 2026)

Evolent Health has reported Payables for 12 years, with the latest figure at $38.8 million in Q2 2026.

• On a quarterly basis, Payables fell 83.93% year-over-year to $38.8 million in Q2 2026; TTM through Jun 2026 was $38.8 million, a 83.93% decrease from a year earlier, with the FY2025 full-year figure at $59.8 million, down 77.65% from the prior year.
• Payables was $38.8 million for Q2 2026 at Evolent Health, down from $63.0 million in the prior quarter.
• The five-year high for Payables was $267.5 million in Q4 2024, with the low at $38.8 million in Q2 2026.
• Average Payables over 5 years is $91.8 million, with a median of $62.4 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Payables jumped 518.96% in 2025, then slumped 83.93% in 2026.
• Over 5 years, Payables stood at $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 454.43% to $267.5 million in 2024, then plunged by 77.65% to $59.8 million in 2025, then tumbled by 35.05% to $38.8 million in 2026.
• The last three Payables figures came in at $38.8 million (Q2 2026), $63.0 million (Q1 2026), and $59.8 million (Q4 2025), per Business Quant data.